Chlorpheniramine Maleate Injection
- Packing: 1 Ml, 2 Ml Ampoule.
- Available Strength : 10 Mg/Ml
Description
Product Description: Chlorpheniramine Maleate Injection is a meticulously crafted pharmaceutical solution designed to provide effective relief from allergy symptoms. It contains chlorpheniramine maleate, a first-generation antihistamine known for its ability to alleviate allergic reactions such as sneezing, itching, and rhinorrhea. Manufactured to the highest quality standards, this injection offers fast and reliable relief from allergy-related discomfort.
Indications and Usage: Chlorpheniramine Maleate Injection is indicated for the symptomatic relief of allergy symptoms, including allergic rhinitis, allergic conjunctivitis, and allergic dermatitis. It is particularly useful in situations where oral administration is not feasible or desirable, or when rapid relief is needed.
Dosage and Administration: The dosage of Chlorpheniramine Maleate Injection varies depending on the patient's age, weight, and the severity of symptoms. It is typically administered via intramuscular or slow intravenous route under the supervision of a qualified healthcare professional. Dosage adjustments may be necessary based on the patient's response to therapy and individual tolerance.
Dosage Forms and Strengths: Chlorpheniramine Maleate Injection is available as a sterile solution in vials containing specific concentrations of chlorpheniramine maleate formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications: This product is contraindicated in patients with a known hypersensitivity to chlorpheniramine or any of the excipients. It should not be used in patients with narrow-angle glaucoma, prostatic hypertrophy, or bladder neck obstruction. Additionally, it is contraindicated in newborns and premature infants.
Warnings and Precautions: Healthcare providers should exercise caution when prescribing Chlorpheniramine Maleate Injection to elderly patients, as they may be more susceptible to anticholinergic effects such as dry mouth, constipation, and urinary retention. Patients should be advised against engaging in activities requiring mental alertness, such as driving or operating machinery, until the effects of the medication are known.
Adverse Reactions/Side Effects: Common adverse reactions associated with Chlorpheniramine Maleate Injection include drowsiness, dizziness, and dry mouth. Rarely, serious adverse effects such as arrhythmias, seizures, and paradoxical excitability may occur. Patients should be advised to report any unusual symptoms promptly.
Drug Interactions: Concomitant use of Chlorpheniramine Maleate Injection with other central nervous system depressants, such as alcohol or sedative-hypnotics, may potentiate the sedative effects of chlorpheniramine. Healthcare providers should review the patient's medication profile carefully to avoid potential drug interactions.
Use In Specific Populations Description: Safety and efficacy of Chlorpheniramine Maleate Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling: Chlorpheniramine Maleate Injection is supplied as a sterile solution in vials for parenteral administration. It should be stored at controlled room temperature away from light and moisture. Care should be taken to avoid freezing or excessive heat exposure. Unused portions should be discarded according to standard procedures for biohazardous waste.
